Trivarx Limited has released a press release.
Stabl-Im clinical trial supply milestone achieved
Earlier from Trivarx
- CRO Engaged to Advance Stabl-Im Phase 1 Trial
- March 2026 Quarterly Activities Report and Appendix 4C
- Dr Danielle Meyrick appointed as CEO
- Appendix 4D & Half-Year Financial Report to 31 December 2025